A study by UCLA researchers is the first to demonstrate a technique for coaxing pluripotent stem cells—which can give rise to every cell type in the body and which can be grown indefinitely in the lab—into becoming mature ...
Jan 17, 2019
1
888
People with Duchenne muscular dystrophy (DMD) can develop an otherwise-rare muscle cancer, called rhabdomyosarcoma, due to the muscle cells' continuous work to rebuild the damaged tissue. However, little is known about how ...
Jan 15, 2019
0
43
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered that squamous cell skin cancers do not require increased glucose to power their development and growth, ...
Jan 9, 2019
0
489
Stopping melanoma from spreading to other parts of the body might be as simple as cutting off the blood supply to the cancer, according to researchers.
Jan 4, 2019
0
253
A jagged little protein appears to be key to how cancer stem cells differentiate and enable metastasis, according to researchers at Rice University and the Duke University School of Medicine.
Jan 3, 2019
0
221
Stem cell transplantation is effective against leukemia. In many cases, however, the transferred immune cells of the donor also attack the recipients' healthy tissue—often with fatal consequences. Researchers at the University ...
Nov 29, 2018
0
396
A contagious facial cancer that has ravaged Tasmanian devils in southern Australia isn't the first place one would look to find the key to advancing cell therapies in humans.
Nov 15, 2018
0
123
Researchers led by a UCLA bioengineer have developed a therapy—based on two types of cells joined into a single unit—that could help strengthen existing treatments for acute myeloid leukemia. One of the cells is a blood ...
Oct 30, 2018
0
118
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...
Oct 12, 2018
0
173
Tissues grown in the lab from stem cells may fail to live up their therapeutic promise because the cells choose their own fate.
Oct 4, 2018
1
153
